Mesenchymal stem cell therapy and its application to bronchopulmonary dysplasia of the preterm neonate. A review
Bronchopulmonary dysplasia (BPD) remains a significant contributor to the morbidity and mortality of infants delivered at very low gestational ages. The therapeutic approach to BPD is essentially preventive and supportive. Inflammation is the key contributor to the disease development. Mesenchymal c...
Saved in:
Main Author: | Gustavo Rocha (Author) |
---|---|
Format: | Book |
Published: |
Publicaciones Permanyer,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
by: Sonali Chaudhury, et al.
Published: (2019) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
by: Yufeng Xi, et al.
Published: (2022) -
Catch-up growth in preterm neonates with bronchopulmonary dysplasia in the first 2 years of life
by: Daniela R. Couto, et al.
Published: (2021) -
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
by: Lidys eRivera, et al.
Published: (2016) -
SURFACTANT THERAPY AND BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN VERY PRETERM INFANTS
by: D. Dobryanskyy, et al.
Published: (2019)